Moderna Inc (MRNA) — Cash Flow Quality Index
Moderna Inc (MRNA) has a Cash Flow Quality Index of -120.46x as of September 2024. Operating cash flow of $-1.57 Billion is below net income of $13.00 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Moderna Inc long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Moderna Inc Cash Flow Quality Index (2021–2022)
Historical Cash Flow Quality Index for Moderna Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check MRNA goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Moderna Inc (2021–2022)
Year-by-year earnings quality comparison for Moderna Inc. For live market cap and the full company financial profile, see Moderna Inc (MRNA) market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 0.60x | $4.98 Billion | $8.36 Billion | ▼ -46.6% |
| 2021 | 1.12x | $13.62 Billion | $12.20 Billion | — |